SELLAS Life Sciences shares are testing new highs. Why is SLS stock breaking out?
What Is Driving SELLAS Life Sciences Stock Higher?The REGAL setup is tightening: the trial is now at 78 of the 80 required survival events needed to unblind final data, which is why the stock reacted so sharply when the 8-K hit and why momentum has stayed elevated into Monday’s follow-through. That "event counter" dynamic is keeping attention on SLS.Critical Moving Averages Levels To Watch for SLSThe longer-term trend remains firmly up: SLS is trading well above its major moving averages, including the 20-day SMA ($8.84), 50-day SMA ($7.22), 100-day SMA ($5.94), and 200-day SMA ($4.17). That "stack" is also bullish (20-day SMA above the 50-day, and the 50-day above the 200-day), which typically keeps dip-buying behavior intact until price starts losing those faster trend lines.Momentum is the main risk flag right now, with RSI at 84.05 — deep in overbought territory — suggesting the rally is stretched and more vulnerable to sharp pullbacks if buyers pause. RSI is essentially a speedometer for the move, and readings this elevated often mean demand is strong, but the stock can cool quickly without changing the bigger uptrend.From a levels standpoint, the stock has already pushed through its prior 52-week high ($12.43), so traders often look for "breakout retests" where former highs can act as support on any dip. Practically, that puts extra focus on nearby trend support such as the 20-day SMA as the first line that bulls typically want to defend during a momentum unwind.
